Nimble Science
Home | Nimble Science | small intestine sampling technology
- Business Model
- B2B
- Website
- nimblesci.com
- Total Funding
- $2.0M
- Last Round
- $2.0M SeedFeb 2023
- Rounds
- 1
About
Health technology company delivering precision GI insights through small intestine sampling technology for biopharma and nutrition innovation.
Summary
Nimble Science is a Biotech company. It has raised $2.0M in total across 1 round, most recently a $2.0M Seed round in Feb 2023. Investors include Fusion Fund, First Spark Ventures and Alumni Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...